Abstract
Many COVID-19 “vaccines" are considered bioweapons and are known to have the ability to cause prion disease. Prion inducing agents have been researched extensively as potential bioweapons and the field of prion research is infiltrated by clandestine bioweapons operatives. In order for prion disease inducers to be an ideal bioweapon the target population needs to believe there is no cure while the attacker knows of an treatment/ antidote to save its own population if there is “blowback”, where the attackers' population gets exposed to the bioweapon. The narrative in the prion field is that there is no effective treatment for prion disease. However false narratives are the norm in the current COVID-19 related bioweapons attack. The author performed a literature search to determine if any effective treatments to COVID “vaccine" induced prion disease may exist but hidden from the public. The author believes several such candidates may exist and their use for treating COVID “vaccine" induced prion disease needs to be explored. These agents include doxycycline and related minocycline, quinacrine and ivermectin. The nature of this paper is speculative in large part because of the use of bioweapons in the current civil war. It is of no surprise to many that people working in government, medicine, science, and the pharmaceutical industry are deliberately trying to cause harm while pretending to help humanity. One only has to read the long list of influential people associated with Mossad operative Jeffrey Epstein to realize the extent of evil in today’s world.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.